A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 14865
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ER
Long Form : estrogen receptor
No. Year Title Co-occurring Abbreviation
2020 A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. ---
2020 Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens. HER2, PR, VAB
2020 Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol. BMI, CI, IDE, IIE, RR
2020 Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer. CNB, CR, HER2, PR
2020 APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status. A3A, A3B
2020 ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. CRISPR
2020 Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. HR, LRR, PR
2020 Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer. AI, AR, CBR, ORR, PFS
2020 Binding specificities of estrogen receptor with perfluorinated compounds: A cross species comparison. PFCs
10  2020 Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer. BC, pam, PAM, SAM
11  2020 Blocking of Estradiol Receptors ERalpha, ERbeta and GPER During Development, Differentially Alters Energy Metabolism in Male and Female Rats. ---
12  2020 Characteristics and outcome of AKT1 E17K-mutant breast cancer defined through AACR GENIE, a clinicogenomic registry. OS
13  2020 Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer. MBC, Mo-MDSCs
14  2020 Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast. DFS, HER2, PMC, PR
15  2020 Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer. BC, BCSS, HR, PR
16  2020 Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer. EPI, ES, NP, PTX
17  2020 Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers. BMI, HER2, NCCN, PR, RS, TNM
18  2020 Curcumin rescues breast cells from epithelial‑mesenchymal transition and invasion induced by anti‑miR‑34a. EMT, HER2, PgR
19  2020 Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge. EGCG, HER2, PR, TNBC
20  2020 Development of A 3D Tissue Slice Culture Model for the Study of Human Endometrial Repair and Regeneration. PR
21  2020 Development of CAPER peptides for the treatment of triple negative breast cancer. AP-1, HER2, PR, TNBC
22  2020 Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk. ADC, DWI, HER2, OR, RS
23  2020 Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update. DCIS, PgR
24  2020 Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. BC, DEGs, ESR1, KM, PgR, RFS
25  2020 Estrogen receptors differentially regulate intracellular calcium handling in human nonasthmatic and asthmatic airway smooth muscle cells. ASM
26  2020 Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer. HER2, MS, NaCT, pCR, RS
27  2020 Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling. GPX1, PR, TNBC
28  2020 High expression of soluble CD155 in estrogen receptor-negative breast cancer. CTLs, NK, sCD155
29  2020 Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer. AR, GR, PR
30  2020 Liposomes and drug-in-cyclodextrin-in-liposomes formulations encapsulating 17beta-estradiol: An innovative drug delivery system that prevents the activation of the membrane-initiated steroid signaling (MISS) of estrogen receptor alpha. DCL, MISS
31  2020 Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway. ---
32  2020 MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer. BC, MAGUK, TNBC
33  2020 Metabolism of cyclic phenones in rainbow trout in vitro assays. CBP, CPK, rt, VTG
34  2020 Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype. BrCa
35  2020 pH-responsive allochroic nanoparticles for the multicolor detection of breast cancer biomarkers. Ab, BSA, HER2, PR
36  2020 Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells. NCOA3, p-AKT, PLB
37  2020 Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5years after diagnosis and late recurrence. NLR
38  2020 Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models. ---
39  2020 Prevalence of Molecular Subtypes of Breast Cancer: A Single Institutional Experience of 2062 Patients. PR
40  2020 Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer. OS, PgR, SNPs
41  2020 Prognostic genes of triple-negative breast cancer identified by weighted gene co-expression network analysis. DEG, gipc1, HES6, MYLK2, OS, PPAN, PR, TNBC, WGCNA
42  2020 Protein‑ and growth‑modulatory effects of carcinoma‑associated fibroblasts on breast cancer cells: Role of interleukin‑6. ABCG2, CAFs, CM
43  2020 Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer. DDFS, SPBC, TILs
44  2020 Selective activation of estrogen receptor beta alleviates cerebral ischemia neuroinflammatory injury. MCAO-R, OGD-R
45  2020 Selective estrogen receptor (ER)beta activation provokes a redistribution of fat mass and modifies hepatic triglyceride composition in obese male mice. CD, DIP, HFD
46  2020 Sex-specific estrogen regulation of hypothalamic astrocyte estrogen receptor expression and glycogen metabolism in rats. AMPK, GPER, GS
47  2020 Steroidogenic acute regulatory protein transcription is regulated by estrogen receptor signaling in largemouth bass ovary. ChIP, ESR1, hCG, StAR
48  2020 Tamoxifen-induced hepatotoxicity via lipid accumulation and inflammation in zebrafish. ---
49  2020 Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society. DFS, HER2
50  2020 The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-beta1 signaling in rats. D2R, LXT, TGF
51  2020 The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: The Cancer Genome Atlas Network. BMI, SBS, SCNV, TSMB
52  2020 [Expression of HMGB1 protein in breast cancer and its clinicopathological significance]. HMGB1, PR
53  2019 17beta-Estradiol Activates HSF1 via MAPK Signaling in ERalpha-Positive Breast Cancer Cells. HSF1
54  2019 17beta-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy. ---
55  2019 17beta-Estradiol nongenomically induces vascular endothelial H2S release by promoting phosphorylation of cystathionine gamma-lyase. CSE, HUVECs, pGC-A, PKGI
56  2019 17beta-Estradiol protects mesenchymal stem cells against high glucose-induced mitochondrial oxidants production via Nrf2/Sirt3/MnSOD signaling. hUCB-MSCs, MnSOD, mtROS
57  2019 18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CT. 18F-FDG, 18F-FES, CT, PET
58  2019 18F-fluorodeoxyglucose PET/computed tomography in locoregional staging and assessment of biological and clinical aggressiveness of breast cancer subtypes. 18F-FDG, ALN, AUC, CT, NPV, PPV, PR
59  2019 18F-Fluoroestradiol PET Imaging of Activating Estrogen Receptor-alpha Mutations in Breast Cancer. 18F-FES, WT
60  2019 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells. BC
61  2019 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer. RS, SEER
62  2019 24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo. ---
63  2019 A Case of Locally Advanced Breast Cancer in a 59-Year-Old Man Requiring a Modified Approach to Management. HER2, PR
64  2019 A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. CN, FISH, WT
65  2019 A deletion mutation within the ATBF1 gene is strongly associated with goat litter size. SWCG
66  2019 A functional single nucleotide polymorphism in ABCC11, rs17822931, is associated with the risk of breast cancer in Japanese. ABC, CIs, HERPACC II, ORs, SNP
67  2019 A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study). BCS, BCSS, DCIS, ET, FSM, LR, RT
68  2019 A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study. AUC, CNB, HER2, PR
69  2019 A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer. CI, HER2, LVI, ODX, PR
70  2019 A nongenomic mechanism for "metalloestrogenic" effects of cadmium in human uterine leiomyoma cells through G protein-coupled estrogen receptor. Cd, EGFR, GPER, HB-EGF, MMP2, si
71  2019 A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting gamma-secretase-mediated activation of Notch signaling. BC, EMT, GSIs, NICD, PR
72  2019 A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer. AUC, NOLUS, PR
73  2019 A Pooled Analysis of Breastfeeding and Breast Cancer Risk by Hormone Receptor Status in Parous Hispanic Women. CIs, ORs, PR
74  2019 A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy. lncRNAs
75  2019 A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study). pCR, RCB
76  2019 A Reappraisal of the Comparative Effectiveness of Lumpectomy Versus Mastectomy on Breast Cancer Survival: A Propensity Score-Matched Update From the National Cancer Data Base (NCDB). CI, HR, NCDB, OS, PSM
77  2019 A Retrospective Study of the Imaging and Pathological Features of Metaplastic Breast Carcinoma and Review of the Literature. ADC, DWI, MBC, MRI, PR, T2WI, TIC
78  2019 A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. TDO, TNBC
79  2019 A Standardized Evaluation Method for FOXP3+ Tregs and CD8+ T-cells in Breast Carcinoma: Association With Breast Carcinoma Subtypes, Stage and Prognosis. BC, BCSS, sTILs, TNBCs
80  2019 Abemaciclib, a potent cyclin-dependent kinase 4 and 6 inhibitor, for treatment of ER-positive metastatic breast cancer. ---
81  2019 Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer. AI, BRCA2, DEGs, GO, RAD51
82  2019 Abilities of beta-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. PDAC
83  2019 Abnormal expression of estrogen receptor is associated with thin endometrium. PR
84  2019 Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer. IHC, NAC, PR
85  2019 Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies. HER2, IHC, RT-PCR
86  2019 Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies. ---
87  2019 Activation of hepatic estrogen receptor-alpha increases energy expenditure by stimulating the production of fibroblast growth factor 21 in female mice. FGF21
88  2019 Acute estradiol treatment reduces skeletal muscle protein breakdown markers in early- but not late-postmenopausal women. FOXO3, MHC, MuRF1
89  2019 Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging. ADC, HER2, IDC, PR
90  2019 Adrenal Steroids Modulate Fibroblast-Like Synoviocytes Response During B. abortus Infection. DHEA, GR, HSD
91  2019 AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs). 3-MC, AhR, CAFs, GPER
92  2019 Akt and estrogen receptor expression in nasal polyps. NP
93  2019 Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC). BC, BOADICEA, CI, FRP, HR, ProF-SC
94  2019 Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy. AI, AR, PKIB, SGK3
95  2019 AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. AMPK, HER2, PR, TNBC
96  2019 Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland. AREG, RSPO1
97  2019 An aptasensor for rapid and sensitive detection of estrogen receptor alpha in human breast cancer. ELISA, IHC
98  2019 An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment. ---
99  2019 An evaluation of fulvestrant for the treatment of metastatic breast cancer. ABC, SERD
100  2019 Analogues of ERbeta ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis. IL, OL